advancing innovation to save lives

Blog: Funding by crisis is no cure for global health threats

In a Breakthroughs blog post, Stephen Higgs of ASTMH and Erin Will Morton of GHTC call for US policymakers to stop funding by crisis and commit to sustainable, long-term investment in global health R&D.
View

GHTC report outlines US policy actions to advance health R&D

GHTC launched its seventh annual policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D, which draws on the momentum of the new global goals, challenging US leadership to match a bold vision for global health with a bold vision to advance global health R&D.
Learn More

Member Spotlight: Aeras

Aeras launched a 90-second video on World TB Day to raise awareness about the need for new tools, including vaccines, to fight the TB epidemic.
View

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Will Boase
Science Speaks covers GHTC briefing, report release

Science Speaks highlights remarks made at a congressional briefing to release GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D.

View
PATH/Patrick McKern
RAPS highlights regulatory recommendations from GHTC policy report

The Regulatory Affairs Professionals Society's (RAPS) Regulatory Focus explores the regulatory policy actions recommended in GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D, including a recommendation for the US Food and Drug Administration to create a mechanism to review health products for use outside the United States.

View
View All News & Events

Community Event

PATH/Aaron Joel Santos
Open Ended Meeting WHO Report on CEWG
World Health Organization
Learn More

Community Event

Women Deliver: 4th Global Conference
Women Deliver
Learn More
View All Events
PATH/Lesley Reed
Incentives and innovative financing mechanisms matter in addressing market failures

When existing market forces alone fall short in ensuring availability of and access to lifesaving health tools, a range of interventions are needed to alter the market and ultimately change the behavior of its actors.

Read More
GHTC/Marissa Chmiola
GHTC briefing highlights critical role of US government in advancing global health innovation in an increasingly globalized world

On Tuesday, GHTC launched our seventh annual policy report through a congressional briefing and panel discussion. The critical role played by the US government in catalyzing global health research and development was a recurring theme, as panelists discussed the interconnectedness of global and American health and emphasized the need for new health tools to protect against outbreaks and continue progress.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide